Ayal A. Aizer, MD

To evaluate the clinical accuracy and utility of a commercial deep learning-based auto-segmentation tool by Siemens for delineating brain metastases (GTV) and organs-at-risk (OAR) on contrast-enhanced MRI.

The efficacy of stereotactic radiosurgery (SRS) and radiotherapy (SRT) for brain metastases is often compromised by tumor growth and soft tissue changes between simulation and treatment. To eliminate these latencies, we clinically implemented a novel same-day...